Companies / BOC Sciences / Flanvotumab
BOC Sciences

Flanvotumab | BOC Sciences

Flanvotumab is a human monoclonal antibody directed against tyrosinase-related protein (TYRP1). Flanvotumab binds to gp75, resulting in the induction of cytotoxic T cell immune and antibody-mediated immune responses against melanoma cells expressing gp75.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.